keyboard_arrow_up

Deep Research Analysis on Europe Markets for Orthopedic Biomaterials 2011-2021

Europe Markets for Orthopedic Biomaterials 2011-2021 is a new market research publication announced by Reportstack. The European orthopedic biomaterials market includes bone graft substitutes (BGS), hyaluronic acid (HA) viscosupplementation injections, bone morphogenetic protein (BMP) growth factor therapy and autologous chondrocyte implantations (ACI). The HA market experienced significant contractions in 2012 and 2013 due to the extreme price competition resulting from an increase in competition, especially in Germany.

Scope
2011-2021


Companies Mentioned

Fidia Medtronic Sanofi Smith and Nephew Meda Pharma TRB Chemedica Depuy Synthes Laboratoire Genevrier Recordati Stryker RTI Biologics Tedec Meiji Sobi Biomet Croma-Pharma Wright Medical Zimmer Fin-Ceramica Baxter Bonalive Seikagaku

To access full report with TOC, please visit Europe Markets for Orthopedic Biomaterials 2011-2021.

Snapshot of TOC

TABLE OF CONTENTS I
LIST OF FIGURES V
LIST OF CHARTS XIII
EXECUTIVE SUMMARY 1
1.1 EUROPEAN MARKETS FOR ORTHOPEDIC BIOMATERIALS 1
1.2 BONE GRAFT SUBSTITUTE MARKET 2
1.3 ALLOGRAFT BONE GRAFT SUBSTITUTE MARKET 3
1.4 SYNTHETIC BONE GRAFT SUBSTITUTE MARKET 4
1.5 DEMINERALIZED BONE MATRIX BONE GRAFT SUBSTITUTE MARKET 5
1.6 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 6
1.7 BONE MORPHOGENETIC PROTEIN GROWTH FACTOR MARKET 7
1.8 AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET 8
1.9 COMPETITIVE ANALYSIS 9
RESEARCH METHODOLOGY 11
2.1 RESEARCH SCOPE 11
2.2 IDATA’S 9-STEP METHODOLOGY 11
Step 1: Project Initiation & Team Selection 11
Step 2: Prepare Data Systems and Perform Secondary Research 13
Step 3: Preparation for Interviews & Questionnaire Design 14
Step 4: Performing Primary Research 15
Step 5: Research Analysis: Establishing Baseline Estimates 17
Step 6: Market Forecast and Analysis 18
Step 7: Identify Strategic Opportunities 20
Step 8: Final Review and Market Release 21
Step 9: Customer Feedback and Market Monitoring 22
EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET 23
3.1 INTRODUCTION 23
3.1.1 Products 24
3.1.1.1 Growth Factors 24
3.1.1.2 Bone Graft Substitutes 24
3.1.1.3 Hyaluronic Acid Viscosupplementation 24
3.1.1.4 Autologous Chondrocyte Implantation 24
3.2 CURRENCY EXCHANGE RATE 25
3.3 MARKET OVERVIEW 26
3.4 TREND ANALYSIS 32
3.5 DRIVERS AND LIMITERS 35
3.5.1 Market Drivers 35
3.5.2 Market Limiters 36
3.6 COMPETITIVE ANALYSIS 38
3.7 MERGERS AND ACQUISITIONS 44
COUNTRY PROFILES 47
4.1 INTRODUCTION 47
4.1.1 Population 47
4.1.2 GDP per Capita 47
4.1.3 Price Index 47
4.2 GERMANY 48
4.3 FRANCE 49
4.4 UNITED KINGDOM 50
4.5 ITALY 51
4.6 SPAIN 52
4.7 BENELUX 53
4.8 SCANDINAVIA 54
4.9 AUSTRIA 55
4.10 SWITZERLAND 56
4.11 PORTUGAL 57

BONE GRAFT SUBSTITUTE MARKET 59
5.1 INTRODUCTION 59
5.1.1 Volumes Represented per Procedure 61
5.2 MARKET OVERVIEW 63
5.2.1 Bone Graft Substitute Market by Indication 63
5.2.2 Bone Graft Substitute Market by Segment 67
5.3 MARKET ANALYSIS AND FORECAST 70
5.3.1 Total Bone Graft Substitute Market 71
5.3.2 Total Allograft Market 80
5.3.2.1 Total Allograft Spine Market 90
5.3.2.1.1 Allograft Cervical Spine Market 99
5.3.2.1.2 Allograft Thoracolumbar Spine Market 107
5.3.2.2 Allograft Trauma and Reconstruction Market 115
5.3.2.3 Allograft Craniomaxillofacial Market 124
5.3.3 Total Synthetic Market 133
5.3.3.1 Total Synthetic Spine Market 143
5.3.3.1.1 Synthetic Cervical Spine Market 152
5.3.3.1.2 Synthetic Thoracolumbar Spine Market 160
5.3.3.2 Synthetic Trauma and Reconstruction Market 168
5.3.3.3 Synthetic Craniomaxillofacial Market 177
5.3.4 Total Demineralized Bone Matrix Market 186
5.3.4.1 Total Demineralized Bone Matrix Spine Market 196
5.3.4.1.1 Demineralized Bone Matrix Cervical Spine Market 205
5.3.4.1.2 Demineralized Bone Matrix Thoracolumbar Spine Market 213
5.3.4.2 Demineralized Bone Matrix Trauma and Reconstruction Market 221
5.3.4.3 Demineralized Bone Matrix Craniomaxillofacial Market 230
5.4 DRIVERS AND LIMITERS 239
5.4.1 Market Drivers 239
5.4.2 Market Limiters 240
5.5 COMPETITIVE ANALYSIS 242

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 247
6.1 INTRODUCTION 247
6.2 MARKET OVERVIEW 249
6.3 MARKET ANALYSIS AND FORECAST 253
6.3.1 Total Hyaluronic Acid Viscosupplementation Market 253
6.3.2 Single-Injection Market 262
6.3.3 Three-Injection Market 271
6.3.4 Five-Injection Market 280
6.4 DRIVERS AND LIMITERS 289
6.4.1 Market Drivers 289
6.4.2 Market Limiters 290
6.5 COMPETITIVE ANALYSIS 292
BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET 297
7.1 INTRODUCTION 297
7.2 MARKET ANALYSIS AND FORECAST 299
7.3 MARKET DRIVERS AND LIMITERS 306
7.3.1 Market Drivers 306
7.3.2 Market Limiters 306
7.4 COMPETITIVE ANALYSIS 308
AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET 311
8.1 INTRODUCTION 311
8.1.1 Future of ACI Treatments 312
8.2 MARKET ANALYSIS AND FORECAST 313
8.3 DRIVERS AND LIMITERS 320
8.3.1 Market Drivers 320
8.3.2 Market Limiters 321
8.4 COMPETITIVE ANALYSIS 322
ABBREVIATIONS 325

Contact:

Debora White
Manager - Marketing 
debora@reportstack.com
Ph: +1-888-789-6604
Reportstack Market Research
###